Adisseo and Seventure Partners announce €24m first close of new fund for Animal Health and Nutrition

636573060733766439animalfeedcrop.jpg

22 Mar 2018 --- French venture capital firm Seventure Partners has launched a venture capital fund targeted at supporting companies in the field of animal health, feed and nutrition, called AVF. The first close of AVF, at €24 million, is corner stoned by Adisseo, an industry heavyweight in the animal feed sector. AVF’s investment strategy will reportedly focus on two segments at the forefront of the modern agricultural and livestock revolution: animal health, feed and nutrition and digital technologies serving the livestock industry.

The rapidly growing world population and the increased demand from emerging countries for animal protein present significant challenges to the sector, as well as the requirement to meet environmental objectives and for sustainable production within livestock industry. As a result, the livestock sector is undergoing profound changes requiring the entire food chain to adapt accordingly. Within the animal health sector, food digestibility, its nutritional value and energy potential and the traceability of the entire animal food chain are major opportunities, Seventure notes.

In addition to the animal health and nutrition sector, the digital agricultural technology field has seen exponential growth. AVF will also finance digital innovations applied to the livestock value chain, such as smart breeding and diagnosis, control and traceability tools, Seventure reports.

AVF is to primarily invest in innovative companies in Europe, North America and Israel, but will also be open to strong investment proposals from other geographies, including Asia.

“Since the implementation of our new strategy in 2013, we have launched several institutional funds with defined investment themes, connecting prestigious strategic investors with serial entrepreneurs and financial institutional investors,” states Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners.

“We have launched funds in Digital technologies as well as in Life sciences. After the successful launch of Health for Life Capital, which raised €160 million with strategic partners such as Danone, Novartis, Tereos, Lesaffre and Bel to invest in the microbiome, digital innovation and in human health/nutrition/food, we are now launching AVF, a new fund in animal health and nutrition.”

Commenting on the need for and focus of the fund, Isabelle de Cremoux added: “This new thematic fund was created to address a very specific and expanding need in the market: preserving animal health, gaining a better understanding of the entire food value chain, as well as developing technologies to cultivate and produce food in a better way.

Jean-Marc Dublanc, CEO of Adisseo, states: “Adisseo is a unique company committed to strategic investments in new disruptive technologies, in order to enrich our portfolio of R&D innovations while respecting a mode of sustainable growth. Our ambition is to become one of the leaders in Feed Ingredient Specialties and the experienced partner of choice in animal nutrition.”

“With AVF, our goal is to invest in strategic collaborations combining the agility of start-ups with Adisseo’s expertise. As such, Seventure was a natural partner of choice and we are pleased to become a strategic investor in AVF,” Dublanc concludes.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Weekly Roundup: Changes to meal times can reduce body fat, GRAS status for Aurea Biolabs' sports nutrition ingredient

07 Sep 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. Researchers have used peanut DNA to develop a detection method for traces of peanut, while a study suggested that slightly adjusting meal times could decrease body fat by twofold. The European Commission appointed a new Director-General to its health and food safety department. Aurea Biolabs' sports nutrition ingredient, Fitnox, obtained GRAS status and Seventure Partners unveiled its corporate update for the period May-August 2018.

Health & Nutrition News

From lab to market: A-Mansia secures funding for “unique” gut health products

30 Apr 2018 --- Belgian microbiome company A-Mansia Biotech has raised €13 million in first close Series A financing, pushing forward development of one their unique discoveries – the most abundant bacterial species of the gut microbiome – Akkermansia muciniphila (A. muciniphila) bacterium. The company is developing health products from the bacterium, which has been proven in laboratory conditions to prevent the development of disorders induced by a high-fat diet, i.e. cholesterol and weight-gain.

Business News

Seventure Partners’ microbiome portfolio nears critical milestones 

18 Dec 2017 --- Seventure Partners, one of Europe’s leaders in financing innovation, and a world-leader in the venture investment in the microbiome sector, is seeing rapid progress from innovation into human trials, with five of its portfolio companies advancing their human microbiome products with varying modalities and therapeutics targets in clinical trials.

Business News

LNC Therapeutics raises €6.5m to reinforce its R&D in the microbiota field

29 Sep 2017 --- LNC Therapeutics, a company specialized in the research and development of gut microbiota directed drugs for the treatment of obesity and associated cardiometabolic diseases, has raised a €6.5 million (US$7.67 million) Series C funding round. This new round, co-led by Seventure Partners, brings together a consortium of investors and a family office. Additionally, the company has appointed a new chief scientific officer, Dr. Sandrine Claus, to lead the gut microbiota project.

Health & Nutrition News

Gut Reaction – Microbiome Can Predict Body’s Response to Junk Foods

06 Jul 2017 --- Chemical signatures from gut bacteria which show up in urine can be used to predict how the body will respond to a “junk” diet. This is according to new research that has shown that certain compounds, produced by microbes in the guts of mice, could be used to show which animals are at greater risk of becoming obese or developing health conditions such as diabetes or cardiovascular disease (CVD).

More Articles
URL : http://www.nutritioninsight.com:80/news/adisseo-and-seventure-partners-announce-%E2%82%AC24m-first-close-of-new-fund-for-animal-health-and-nutrition.html